Illumina launches fast, flexible whole-genome sequencing solution for cancer residual disease detection
Illumina has introduced a new whole-genome sequencing (WGS) solution for molecular residual disease (MRD) research, enabling faster and more flexible detection of cancer residuals during and after treatment. This distributed kit supports both solid t...
